EVHEvolent Health, Inc.
Price
-51%1YEnd-of-day closes, not the intraday tick.
The checks lean against it
Quality shaky, a flag to check, growth fading, the market undecided.
Charts
As reported to the SEC, without any scoring.
Evolent Health, Inc. (EVH) reported revenue of $653M in Q2 2026 (quarter ended Jun 30, 2026), up 47% from the same quarter a year earlier. That came with a gross margin of 12% and net loss of $28M. For the full year FY2025, revenue was $1.88B (−27% year on year) and net income −$535M. The next results filing is expected around Nov 5, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 6, 2026Evolent Announces Second Quarter 2026 Results.Earnings release · press release
- May 7, 2026Evolent Announces First Quarter 2026 Results.Earnings release · press release
- Feb 24, 2026Evolent Announces Fourth Quarter 2025 Results and Full Year 2025 Results.Earnings release · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Health Information Services
Ranks #19 of 20 by RyuScore